Kelly Kugler

2.8k citations
6 papers · 605 indexed · h-index 4
Topics
Lung Cancer Treatments and Mutations (4 papers)Cancer Genomics and Diagnostics (3 papers)Lung Cancer Research Studies (3 papers)
Partner nations
United StatesGermany

In The Last Decade

Kelly Kugler

6 papers receiving 584 citations

Peers

Kelly Kugler
Comparison fields: 5 of 49
  • Pulmonary and Respiratory Medicine 498
  • Oncology 313
  • Molecular Biology 231
  • Cancer Research 213
  • Pathology and Forensic Medicine 62
Replace Raquel Esgueva with:
Raquel Esgueva United States
Liana B. Guedes United States
Nick Beije Netherlands
Adnan Hasanovic United States
Alberto Cambieri Italy
Tzu‐Hsiu Tsai Taiwan
Assa Oumie United Kingdom
Eamon M. Berge United States
Shuji Ichihara Japan
R. McCormack United Kingdom
Kelly Kugler relative to Raquel Esgueva United States Raquel Esgueva's profile →
Citations per field
00.5×2.6×
Raquel Esgueva · 1×
Citations per year

Countries citing papers authored by Kelly Kugler

Since Specialization
Citations

This map shows the geographic impact of Kelly Kugler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Kugler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Kugler more than expected).

Fields of papers citing papers by Kelly Kugler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly Kugler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Kugler. The network helps show where Kelly Kugler may publish in the future.

Co-authorship network of co-authors of Kelly Kugler

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Kugler. A scholar is included among the top collaborators of Kelly Kugler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Kugler. Kelly Kugler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1 303
2 94
3 2
4 176
5 3
6 27

About Kelly Kugler

Kelly Kugler is a scholar working on Cancer Research, Urology and Pulmonary and Respiratory Medicine, having authored 6 papers that have together received 605 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (4 papers), Cancer Genomics and Diagnostics (3 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (498 citations), Cancer Research (213 citations) and Oncology (313 citations). Kelly Kugler has collaborated with scholars based in United States and Germany. Frequent co-authors include A. John Iafrate, Mark G. Kris, Lynne D. Berry, John D. Minna, Ignacio I. Wistuba, Bruce E. Johnson, Wilbur A. Franklin, Paul A. Bunn, David J. Kwiatkowski and Junya Fujimoto. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026